← ADMA BIOLOGICS, INC. ADMA
Market Price
$9.48
Market Cap
$2.18B
P/E Ratio
15.80
Revenue (FY 2025)
↑19.6% YoY
$510.17M
3-Yr CAGR: 49.0%
Net Income
↓-25.7% YoY
$146.93M
Net Margin: 28.8%
Free Cash Flow
↓-74.8% YoY
$27.82M
FCF Yield: 1.28%
EPS (Diluted)
↓-25.9% YoY
$0.60
Basic: $0.62
Return on Equity
Efficiency
30.8%
ROA: 1,970.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ADMA)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $10.5M | — | $4.3M | $-19.5M | — | $-1.61 | — | $-18.3M | $-18.3M | — |
| FY 2017 | $15.6M | +48.5% | $-6.4M | $-43.8M | -124.2% | $-1.91 | -18.6% | $-37.3M | $-39.9M | -117.8% |
| FY 2018 | $17.0M | +8.8% | $-25.2M | $-65.7M | -50.2% | $-1.45 | +24.1% | $-62.7M | $-64.8M | -62.1% |
| FY 2019 | $29.3M | +72.8% | $14.1M | $-48.3M | +26.6% | $-0.89 | +38.6% | $-76.2M | $-80.0M | -23.5% |
| FY 2020 | $42.2M | +43.9% | $-19.1M | $-75.7M | -56.9% | $-0.88 | +1.1% | $-102.0M | $-114.7M | -43.4% |
| FY 2021 | $80.9M | +91.7% | $1.2M | $-71.6M | +5.4% | $-0.51 | +42.0% | $-112.4M | $-125.9M | -9.7% |
| FY 2022 | $154.1M | +90.4% | $35.3M | $-65.9M | +8.0% | $-0.33 | +35.3% | $-59.5M | $-73.4M | +41.7% |
| FY 2023 | $258.2M | +67.6% | $88.9M | $-28.2M | +57.2% | $-0.13 | +60.6% | $8.8M | $4.0M | +105.5% |
| FY 2024 | $426.5M | +65.2% | $219.6M | $197.7M | +800.0% | $0.81 | +723.1% | $118.7M | $110.4M | +2,641.3% |
| FY 2025 | $510.2M | +19.6% | $292.8M | $146.9M | -25.7% | $0.60 | -25.9% | $50.4M | $27.8M | -74.8% |
Valuation
Market Price
$9.48
Market Cap
$2.18B
Enterprise Value
$2.17B
P/E Ratio
15.80
P/B Ratio
4.60
FCF Yield
1.28%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
57.39%
Operating Margin
37.53%
Net Margin
28.80%
Return on Equity (ROE)
30.78%
Return on Assets (ROA)
1,970.10%
Asset Turnover
68.41x
Revenue 3-Yr CAGR
49.05%
Financial Health & Liquidity
Current Ratio
0.18
Cash Ratio
2.17
Debt / Equity
0.151
Debt / Assets
9.673
Cash & Equivalents
$87.63M
Total Debt
$72.14M
Book Value / Share
$2.06
Cash Flow Efficiency
Operating Cash Flow
$50.40M
Capital Expenditures (CapEx)
$22.57M
Free Cash Flow
$27.82M
OCF / Revenue
9.88%
FCF / Revenue
5.45%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.60
EPS (Basic)
$0.62
Dividends / Share
N/A
Book Value / Share
$2.06
EPS YoY Growth
-25.93%
Balance Sheet (FY 2025)
Total Assets
$7.46M
Total Liabilities
$40.47M
Stockholders' Equity
$477.32M
Current Assets
$7.46M
Current Liabilities
$40.47M